Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александр Владимирович Пиптюк, Святослав Богданович Телемуха, Владимир Александрович ПиптюкfiledCriticalАлександр Владимирович Пиптюк
Priority to UAU201211631UpriorityCriticalpatent/UA80570U/en
Publication of UA80570UpublicationCriticalpatent/UA80570U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for treating purulonecrotic processes in diabetes mellitus consists in cannulation of the inferior epigastric artery followed by intra-arterial administration of the drugs. Furthermore, fibrinolysin and heparin are administered regionally at a dose of 2,000 U and 1,000 U, correspondingly, for 170-180 minutes once a day for 5-7 days.
UAU201211631U2012-10-082012-10-08Method for treating purulonecrotic processes in diabetes mellitus
UA80570U
(en)